Chong Kun Dang Pharmaceutical

This early-stage study tested the safety and how the body processes an experimental drug called CKD-508 in healthy volunteers. Forty-four healthy adults received either the drug or a placebo to check for side effects and measure how the drug moves through the body. Researchers al…

This early-stage study tested how a new combination pill for type 2 diabetes (CKD-383) is absorbed and processed by the body, compared to taking its three separate drug components. It involved 31 healthy adult volunteers who each received both the single pill and the separate pil…

This early-stage study tested how a potential new drug called CKD-846 moves through the body and how safe it is. The trial involved 31 healthy male volunteers who received the drug. Researchers measured drug levels in the blood over time to understand how the body processes it.

This early-stage study aims to understand how an experimental heart drug called CKD-508 interacts with two common medications (midazolam and rosuvastatin) in the body. It involved 24 healthy adult male volunteers to measure drug levels and check for safety. The goal is to gather …

This early-stage study tested how the body absorbs and processes a new combination pill for type 2 diabetes, called CKD-383, compared to taking its three separate drug components. The study involved 30 healthy adult volunteers who took each treatment once, with a week break in be…

This early-stage study aimed to understand how the body processes a new combination diabetes medication (CKD-383) compared to taking its three separate components together. The study involved 30 healthy adult volunteers who received both treatments in a specific order with a brea…